MCUJF
MCUJF clinical trials: MEDICURE INC
Every trial on ClinicalTrials.gov where MEDICURE INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MCUJF on the catalyst calendar · MCUJF registry changes
- Primary completion Sep 2027Sponsor estimatePhase 3NCT04706013Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO DeficiencyMedicure · Pyridox(am)Ine 5'-Phosphate Oxidase DeficiencyActive, not recruitingMCUJFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 15, 2029Sponsor estimatePhase 3NCT07928388Continuation Study With Oral MC-1 for Treatment of Patients With PNPO-DeficiencyMedicure · Pyridox(am)Ine 5'-Phosphate Oxidase DeficiencyRecruitingMCUJFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2018ActualPhase 2NCT01522417Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary InterventionMedicure · Myocardial InfarctionCompletedMCUJFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2012ActualPhase 2NCT00917293Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive DyskinesiaMedicure · Tardive DyskinesiaTerminatedMCUJFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 3NCT01245725Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary InterventionMedicure · Myocardial InfarctionWithdrawnMCUJFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2013ActualPhase 1NCT01766154Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal FunctionMedicure · Renal InsufficiencyCompletedMCUJFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 3NCT00402506A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABGMedicure · Coronary Artery Bypass Graft SurgeryCompletedMCUJFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00157729MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)Medicure · Diabetes Mellitus Type 2CompletedMCUJFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00157716MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)Medicure · Coronary Artery Bypass Graft SurgeryCompletedMCUJFLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner